Medicare provides insufficient access to opioid addiction treatment, report finds
Medicare is vastly underserving older Americans with opioid use disorder, with only 18% of enrollees…
Author: STAT
Tell us about your experience with telehealth linked to pharma companies
Drug ads have long tried to influence patients’ medical choices, directing them to “ask your…
STAT+: Pharmalittle: Pharma pursues the ‘dream’ of online prescribing; EC chief under fire over Pfizer vaccine contract
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
U.S. to spend more than $2 billion to launch Biden’s biomanufacturing initiative
The federal government is pledging more than $2 billion to launch President Biden’s new national…
STAT+: Medical pioneers team up to launch new cell therapy biotech
Medical pioneers Carl June, Bruce Levine, and Drew Weissman have teamed up to launch a…
Daily multivitamins improved the brain function of seniors in a trial — but plenty of questions remain
While pharma companies struggle to show that cutting-edge therapies can treat, prevent, or slow Alzheimer’s…
Opinion: A challenge trial can streamline testing of hepatitis C vaccines
Trade-offs in medicine can be harsh, even when clearly necessary. Chemotherapy can save people from…
Complexity of Covid vaccine program leads to concerns about potential for error
The rollout of the Covid-19 vaccination program has reached new heights of complexity with the…
Opinion: Listen: A pediatric doctor on the life-or-death decisions some prospective parents must make
Christopher Hartnick never expected his work as a doctor to intersect with political discussions about…
STAT+: ‘This is pharma’s dream’: How drugmakers are turning telehealth into a marketing gold mine
A familiar refrain echoes through drug ads in the United States. It’s heard at the…
.jpg)
An exclusive chat with Talking with Google’s Ivor Horn and the details on Verily’s $1 billion round
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: Biden picks biotech exec to lead new biomedical research agency; FDA to hold meeting for OTC birth control pill
Hello, everyone, and how are you today? The skies over the Pharmalot campus remain gloomy…
STAT+: Akero treatment for NASH reduces liver scarring, achieves goals of mid-stage study
Akero Therapeutics said Tuesday that an experimental medicine improved liver scarring at twice the rate…
Opinion: Vaccine guarantees can help prevent the resurgence of polio
The first case of polio in the U.S. in a decade has triggered intense debate…
Opinion: Health care needs a Black Friday sale: the case for legalizing discounts on medical services
The best time to buy a car is at model year-end sales, and Black Friday…
With a promising new plan to pay for pricey cures, two states set out to eliminate hepatitis C. But cost hasn’t been the biggest problem
WASHINGTON — For nearly a decade, many experts assumed the biggest obstacle to eliminating hepatitis…
Opinion: Medicare needs to update its wheelchair coverage for the 21st century
Both of us have spent much of our lives in wheelchairs. But not just any…
STAT+: Data likely support approval of Amgen’s KRAS-targeted drug, but still come with disappointments
Clinical trial results reported Monday by Amgen may be enough to confirm the U.S. approval…
STAT+: Pretzel Therapeutics, eyeing diseases caused by broken mitochondria, launches with $72.5 million
In the life sciences industry, where company names derived from “biology” or “genetics” are a…
STAT+: Pharmalittle: FDA approves new type of psoriasis drug; U.S. starts late-stage trial to test an antiviral against monkeypox
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Biden appoints former government scientist as first leader of ARPA-H
President Joe Biden plans to appoint longtime biologist and former government scientist Renee Wegrzyn as…
With increased virus activity, providers urged to be alert for signs of rare polio-like syndrome in kids
Pediatricians and top health officials are warning about an uptick in activity of a common…
Raising a RUC-kus, Blues’ antitrust deal appealed, & a UAE deal
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
Opinion: Why do people turn down social risk assistance offered by their doctors’ offices?
After decades of research documenting the profound effects of social factors on health, such as…
Don’t let shrill debates keep you from getting a Covid booster
Even before the new Covid booster shots arrived, the arguments about them got shrill. There’s…
.jpg)
STAT+: Experts urge Medicare to overhaul secretive panel that helps determine doctors’ pay
A heavyweight group of former Medicare officials and payment experts are calling on the federal…
STAT+: Boston’s most valuable biotech? It’s not who you might expect
The brightest star in Boston’s rapidly growing biotech scene isn’t a flashy new player, but…
STAT+: Cancer treatment devised in the 1980s has proven effective (again). Will it finally get approval?
Eight years ago, a Dutch oncologist, John Haanen, set out to change melanoma treatment by…
STAT+: USDA starts cracking down on companies that ship animals without timely inspections
Earlier this year, a leading animal rights group asked U.S. authorities to investigate medical research…
STAT+: J&J wins a partial appeal against the U.K.’s cost-effectiveness watchdog over ‘unfair’ review
In an unusual turn of events, an appeals panel ruled that the U.K.’s cost effectiveness…
STAT+: Home Depot, other employers appeal Blue Cross Blue Shield antitrust settlement
Home improvement retailer Home Depot and two other, smaller employers are appealing a recent $2.67…
STAT+: FDA funding negotiations heat up ahead of September deadline
WASHINGTON — Negotiations are intensifying over massive, multibillion-dollar legislation to fund the Food and Drug…
STAT+: Alphabet spinout Verily raises $1 billion as it looks to harness health data
Alphabet’s life sciences offshoot Verily said Friday that it has raised $1 billion to fuel…
STAT+: Pharmalittle: FDA approves a new wrinkle drug; running remote clinical trials can save pharma money
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Health care’s shift from covenant to commodity comes with consequences
Norman Rockwell’s 1939 painting “When the Doctor Treats Your Child” depicts a family doctor with…
Push to double up on Covid booster and flu shot may have a downside, experts caution
“I really believe this is why God gave us two arms — one for the…
With homicide the leading cause of maternal mortality, new research shows a link to firearms and intimate partner violence
Pregnancy is risky, and Naima Joseph sees the perils firsthand every day. For some patients,…
STAT+: What disclosure? Clinical trials run in Canada fail to take basic steps toward transparency
Amid ongoing controversy over clinical trial transparency, a new analysis found that just 3% of…
Illumina’s $8 billion limbo, a new treatment for ALS, & Emirati biotech funding
Is Illumina a victim of its own success? What makes the FDA change its mind?…
DHS issues rule to revise Trump’s ‘public charge’ policy, easing access to health services for immigrants
The Department of Homeland Security on Thursday issued a new rule to revise a Trump…
An RPM explosion, the latest on Amazon research, & telehealth fraud findings
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Even before Covid-19, remote trials saved money. Will pharma now rely on them more than ever?
Running clinical trials remotely or virtually can provide substantial financial savings for pharmaceutical companies, according…
STAT+: Pharmalittle: FDA advisers recommend approval of controversial ALS drug; judge rules against coverage of HIV prevention drugs
Rise and shine, everyone, another busy day is on the way. We can tell by…
Opinion: Launch prices: tackling the next drug pricing challenge
The passage of the Inflation Reduction Act brings a new era to drug pricing in…
A new report brings telehealth fraud risk into focus
WASHINGTON — Washington’s attempts to permanently lock in telehealth coverage have been hobbled by a…
Opinion: Breaking the ‘corporate medical playbook’ that silences physicians’ reports of inequity
As a woman of color who was fortunate to be accepted to medical school 29…
Fentanyl test strips could help save lives. In many states, they’re still illegal
Nothing has made the nation’s addiction epidemic more deadly than fentanyl’s infiltration of the drug…
STAT+: Advocates wanted Juul’s big settlement to overhaul the e-cigarette landscape. It likely won’t, experts warn
WASHINGTON – On Tuesday, a group of more than 30 attorneys general announced they had…
STAT+: Data show strong results for Alnylam therapy for heart disease, but magnitude of benefit will stir debate
Detailed data from a successful heart disease study show a therapy developed by Alnylam Pharmaceuticals…
STAT+: In reversal, FDA advisers vote a second time to support approval of Amylyx’s drug for ALS
At the end of an unusual and dramatic meeting on Wednesday, an independent panel of…